このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

i-SENS 将来の成長

Future 基準チェック /46

i-SENS利益と収益がそれぞれ年間100.5%と16.1%増加すると予測されています。EPS は年間増加すると予想されています。自己資本利益率は 3 年後に7.5% 100.2%なると予測されています。

主要情報

100.5%

収益成長率

100.2%

EPS成長率

Medical Equipment 収益成長	34.0%
収益成長率	16.1%
将来の株主資本利益率	7.5%
アナリストカバレッジ	Low
最終更新日	07 May 2024

今後の成長に関する最新情報

Recent updates

If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%

Jan 18

Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?

Jan 05

Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?

Dec 24

Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 15

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Dec 02

Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?

Nov 20

業績と収益の成長予測

KOSDAQ:A099190 - アナリストの将来予測と過去の財務データ ( )KRW Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	411,300	N/A	N/A	29,600	1
12/31/2025	379,833	44,000	36,000	22,367	3
12/31/2024	302,000	29,700	13,000	9,800	1
3/31/2024	272,877	-766	-17,322	20,060	N/A
12/31/2023	265,120	3,709	-29,603	13,045	N/A
9/30/2023	255,913	4,843	-18,181	23,853	N/A
6/30/2023	257,387	7,696	-29,225	8,483	N/A
3/31/2023	256,661	7,352	-18,308	8,513	N/A
12/31/2022	264,837	16,138	-16,614	6,653	N/A
9/30/2022	262,067	20,078	-57,431	-6,215	N/A
6/30/2022	252,562	25,059	-36,348	13,431	N/A
3/31/2022	249,178	31,504	-32,860	16,847	N/A
12/31/2021	232,935	25,451	-30,970	17,224	N/A
9/30/2021	225,758	29,923	14,565	27,600	N/A
6/30/2021	217,293	29,022	18,484	30,397	N/A
3/31/2021	211,667	27,286	20,705	29,805	N/A
12/31/2020	203,708	26,839	26,611	34,615	N/A
9/30/2020	201,817	17,606	25,834	33,340	N/A
6/30/2020	199,980	19,878	33,432	39,647	N/A
3/31/2020	193,528	24,733	31,503	38,091	N/A
12/31/2019	189,844	23,426	30,331	37,951	N/A
9/30/2019	184,139	33,949	19,199	29,548	N/A
6/30/2019	181,109	32,287	12,915	21,509	N/A
3/31/2019	175,627	24,622	11,041	21,619	N/A
12/31/2018	172,997	22,619	9,006	19,543	N/A
9/30/2018	168,333	18,247	21,839	31,009	N/A
6/30/2018	162,795	15,450	16,334	27,742	N/A
3/31/2018	159,320	16,437	79	24,542	N/A
12/31/2017	156,964	15,730	N/A	22,376	N/A
9/30/2017	150,725	16,808	N/A	16,489	N/A
6/30/2017	144,108	18,050	N/A	13,498	N/A
3/31/2017	139,709	16,295	N/A	11,232	N/A
12/31/2016	132,468	17,561	N/A	11,727	N/A
9/30/2016	121,640	17,066	N/A	13,337	N/A
6/30/2016	113,583	15,074	N/A	15,711	N/A
3/31/2016	107,804	15,692	N/A	19,331	N/A
12/31/2015	101,921	14,716	N/A	22,559	N/A
9/30/2015	100,074	13,736	N/A	16,645	N/A
6/30/2015	97,317	14,036	N/A	22,532	N/A
3/31/2015	95,553	14,049	N/A	20,377	N/A
12/31/2014	95,608	14,466	N/A	17,845	N/A
9/30/2014	93,515	16,322	N/A	19,312	N/A
6/30/2014	91,059	18,239	N/A	15,562	N/A
3/31/2014	86,720	18,646	N/A	13,830	N/A
12/31/2013	82,863	18,642	N/A	16,190	N/A
9/30/2013	81,970	16,418	N/A	13,014	N/A

アナリストによる今後の成長予測

収入対貯蓄率: A099190は今後 3 年間で収益性が向上すると予測されており、これは貯蓄率 ( 2.5% ) よりも高い成長率であると考えられます。

収益対市場: A099190今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。

高成長収益: A099190今後 3 年以内に収益を上げることが予想されます。

収益対市場: A099190の収益 ( 16.1% ) KR市場 ( 10.5% ) よりも速いペースで成長すると予測されています。

高い収益成長: A099190の収益 ( 16.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: A099190の自己資本利益率は、3年後には低くなると予測されています ( 7.5 %)。

i-SENS 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Consensus EPS estimates fall by 40%

Price target increased by 25% to ₩27,500

Price target decreased by 9.8% to ₩39,700

Consensus forecasts updated

Consensus EPS estimates fall by 10%

Price target increased to ₩40,500

Recent updates

Kwang Dong Pharmaceutical Co., Ltd. (KOSE:A009290) agreed to acquire 29.7% stake in Precision Biosensor, Inc. (KOSDAQ:A335810) from i-SENS, Inc. (KOSDAQ:A099190) from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo for KRW 16.9 billion.

First quarter 2024 earnings released: ₩10.00 loss per share (vs ₩153 profit in 1Q 2023)

i-SENS, Inc. announced that it has received KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd

i-SENS, Inc. announced that it expects to receive KRW 50 billion in funding from NH Investment & Securities Co., Ltd., Atinum Investment Co., Ltd

i-SENS' (KOSDAQ:099190) Conservative Accounting Might Explain Soft Earnings

Full year 2023 earnings: EPS and revenues miss analyst expectations

Upcoming dividend of ₩175 per share at 0.7% yield

Investor sentiment deteriorates as stock falls 16%

Consensus EPS estimates fall by 40%

New major risk - Revenue and earnings growth

Price target increased by 25% to ₩27,500

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 17%

Price target decreased by 9.8% to ₩39,700

Upcoming dividend of ₩300 per share

Less than half of directors are independent

Consensus forecasts updated

Consensus EPS estimates fall by 10%

Price target increased to ₩40,500

Less than half of directors are independent

Upcoming dividend of ₩250 per share

Consensus forecasts updated

Estimating The Fair Value Of i-SENS, Inc. (KOSDAQ:099190)

Consensus forecasts updated

Investor sentiment improved over the past week

Do i-SENS's (KOSDAQ:099190) Earnings Warrant Your Attention?

Is i-SENS (KOSDAQ:099190) Using Too Much Debt?

Is i-SENS, Inc.'s (KOSDAQ:099190) 0.8% Dividend Worth Your Time?

i-SENS, Inc., Annual General Meeting, Mar 26, 2021

New 90-day low: ₩25,050

Will i-SENS (KOSDAQ:099190) Multiply In Value Going Forward?

How Much Of i-SENS, Inc. (KOSDAQ:099190) Do Insiders Own?

If You Had Bought i-SENS' (KOSDAQ:099190) Shares Five Years Ago You Would Be Down 27%

New 90-day low: ₩26,450

Do Its Financials Have Any Role To Play In Driving i-SENS, Inc.'s (KOSDAQ:099190) Stock Up Recently?

Is It Worth Considering i-SENS, Inc. (KOSDAQ:099190) For Its Upcoming Dividend?

New 90-day high: ₩29,650

Does i-SENS's (KOSDAQ:099190) Statutory Profit Adequately Reflect Its Underlying Profit?

i-SENS (KOSDAQ:099190) Could Easily Take On More Debt

Does i-SENS, Inc. (KOSDAQ:099190) Have A Place In Your Dividend Portfolio?

Price target raised to ₩37,000

New 90-day high - ₩30,550

New 90-day high - ₩29,500

Price target lowered to ₩33,000

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘